Coronavirus vaccine mass trials in Russia

RUSSIA / FSU POLITICS - In Brief 08 Sep 2020 by Alex Teddy
On September 8 Moscow announced that a coronavirus vaccine has been rolled out to the public. Up until now it has been mainly administered to soldiers. Now it is being trialed on volunteers from the general public.The vaccine - named Sputnik V- is due to enter general circulation. The Health Ministry voiced its confidence in the efficacy and safety of the vaccine. Medical staff and teacher are to be vaccinated first because they are essential workers in contact with the public. News outlets reported claims that top officials have already been vaccinated with Sputnik V.Gamaleya Research Center produced Sputnik V. Its estimates that 80 million doses are needed for Russia's 140 million people to achieve herd immunity. Over 25 000 people were tested in a Phase 3 Trial. Over 20 countries have ordered a total of a billion doses of Sputnik V.The country has sustained over 1 million cases. Only 18 000 people have died of itForeign reviews of Sputnik V say that is effective but longitudinal studies are needed to ensure that it is truly safe. If the vaccine is as good as Moscow says then this is a major feat for Russia.

Now read on...

Register to sample a report

Register
Sign-in
Forgot your password?
Copyright 2024 GlobalSource Partners. All rights reserved. This is prepared for GlobalSource Partners’ clients and may not be redistributed, reproduced, stored in a retrieval system, retransmitted or disclosed, in whole or in part, or in any form or manner, without the express written consent of GlobalSource Partners. This is distributed simultaneously to our website and other portals used by GlobalSource Partners. The information herein was obtained from various sources and is believed to be reliable but GlobalSource Partners does not warrant its completeness or accuracy. Neither GlobalSource Partners nor any Country Analyst, officer or employee accepts any liability whatsoever for any direct, indirect or consequential damages or losses rising from any use of this or its contents.